AEP Plantations Plc — Investment Research Note

Executive summary

AEP Plantations is a UK-listed operator of ~90,000 ha of oil-palm estates in Indonesia (with a small Malaysian remnant) that produces crude palm oil, palm kernels and biogas/BioCNG. Under a new management team appointed October 2024, the group has re-rated dramatically (+212% by April 2026), completed a rebrand, entered the FTSE 250, and pivoted to inorganic growth with the May 2026 acquisition of PT Pinago Utama for $162m and the July 2026 completion of the smaller PT JJU brownfield in Kalimantan. The most important valuation point today is that with net cash of ~$232m at YE25 (pre-Pinago), a strong CPO price environment, and Pinago adding ~23% to CPO output at an implied earnings multiple in the mid-single digits, AEP is a good-quality cyclical trading close to fair value — but with essentially zero relevance to an AI-receiver strategy.

Fair value estimate

• Range: 175p – 235p per share → implied market cap £670m – £900m (mid ~£785m).
• Methodology: blended P/E and EV/EBITDA on FY26 pro-forma numbers (including a full year of Pinago).
• Key assumptions:
  • Pro-forma revenue ~$600m (FY25 $465m + Pinago FY25 $135m 2026-05-05 acquisition RNS).
  • Pro-forma attributable PAT ~$95–105m (FY25 $91m to owners + ~$18m Pinago PAT).
  • Applied 7–10x P/E on ~£77m attributable earnings ≈ £540m–£770m equity value, plus post-deal net cash of ~£55m and other liquid investments.
  • Cross-check EV/EBITDA: pro-forma EBITDA ~$160m; 6–8x = $960m–$1,280m EV, less minorities ≈ £700m–£950m equity.
• Comparison: vs disclosed market cap of £735.1m, mid fair-value ~£785m implies ~7% upside, with a range of −9% to +22%.
• The valuation is highly sensitive to CPO price assumptions; a normalised CPO price (mid-cycle ~$800/mt CIF Rotterdam) would compress fair value toward 150p; a sustained $1,200+ CPO would push it above 250p 2026-04-30 final results, 2026-06-15 AGM update.

Sector context

• Sector classification confirmed: Consumer Staples / Food, Beverage and Tobacco (ICB); more precisely, a plantation agriculture / soft-commodity producer.
• AEP is above typical UK-listed peers on balance-sheet quality (net cash, no borrowings 2025-12-31 balance sheet) and in line on yields (~19–22 mt/ha FFB, OER ~20%). Growth trajectory is above average due to Pinago acquisition.
• Listed peers: M.P. Evans (MPE.L), R.E.A. Holdings (RE.L), New Britain Palm Oil (delisted); SIPEF (Belgium), Sime Darby Plantation and IOI Corp (Malaysia).

Investment thesis

• Fortress balance sheet funding accretive M&A. $232m cash / no debt at YE25 2026-04-30 final results enabled the $162m Pinago deal to be paid entirely from cash 2026-05-05 RNS, adding 15,400 ha of mature planted area at ~9x standalone earnings — immediately EPS-accretive.
• CPO price tailwind persists into 2026. Group achieved $853/mt ex-mill in 2025 (+7% YoY) and average ex-mill of $859/mt for the first five months of 2026; Indonesian B50 biodiesel mandate (July 2026) provides structural demand support 2026-06-15 AGM trading update, 2026-04-30 final results.
• New mill and replanting programme underwrite volume growth. KAP 9th mill commissioning December 2026 (65% complete at May 2026) supports Kalimantan yields; 10,000 ha replanting programme with higher-yielding Tenera palms improves long-term OER 2026-06-15 AGM update, 2026-04-30 final results.

Key risks

• CPO price cyclicality. 2022 saw a monthly peak of $1,857/mt vs a low of $472/mt in 2018; average ~$780–830/mt over 10 years 2024-04-30 final results. Reversion to mid-cycle would materially compress margins.
• Indonesian policy risk. May 2026 DSI export-centralisation policy adds regulatory friction; historical export bans (2022) and DMO rules can materially disrupt realised prices even when global CPO prices rise 2026-06-15 AGM update, 2024-04-30 final results.
• Concentration in Indonesia and family control. Genton (Lim family estate) holds 53% — governance risk if control passes; ~99% of production is Indonesian, so rupiah/tax/regulatory risk is undiversified 2026-04-30 final results, note 25.

Operating leverage

Palm-oil production has moderate operating leverage: staff, fertiliser and estate maintenance costs scale roughly with hectares, but revenue scales with CPO price × volume — so incremental price is nearly all margin. FY25 revenue rose 25% and PBT rose 35% (both from continuing operations), implying 1.4x operating leverage on price/mix 2026-04-30 final results. Fixed cost base ($66m staff costs + ~$19m depreciation on $465m revenue) means every $50/mt CPO price uplift (~5% of ex-mill price) drops roughly $20m to profit — a 20%+ profit uplift on modest revenue movement. The new KAP mill and Pinago's 120 tph mill add capacity that will be underutilised initially, providing extra operating leverage as third-party FFB intake ramps. However, this is not the software-style operating leverage the investor mandate targets — incremental revenue always requires proportional fertiliser, harvesting labour and logistics costs.

Value-trap signals

None identified. Reasons a plantation cyclical could look cheap-and-stay-cheap are visible but manageable: (i) EU deforestation regulation could impinge on future demand, but AEP's NDPE policy and no direct EU sales insulates the group; (ii) related-party transactions with entities controlled by the late Chairman's estate exist but are disclosed and modest; (iii) South Sumatra loss-makers were divested in 2023 removing a chronic drag. Growth is real (Pinago), cash is real, and dividend has risen from 5.0¢ (2021) to 81.0¢ (2025).

Earnings vs. expectations

Company doesn't publish formal guidance or disclose consensus, but management commentary provides a reasonable proxy. H1 2025: management guided in June 2025 to "satisfactory performance for the remaining months" — delivered H1 revenue +39%, PBT +78% 2025-08-11 interim results — a clear beat. FY 2025: management flagged "sustainable performance" — delivered revenue +25%, PBT +35% 2026-04-30 final results — a beat vs a conservative outlook. AGM June 2026: management said "confident of achieving market expectations for 2026" — 5-month operating data shows FFB -2.7%, CPO -1.8%, but Pinago consolidation drives growth 2026-06-15 AGM update. Pattern: management guides conservatively, delivers modest to material beats.

Conviction

Conviction: 3 (moderate).

• Supports: clean balance sheet, unqualified audit, tangible plantation asset base, disclosed acquisition economics (Pinago P/E ~9x), consistent management commentary matching outcomes.
• Limits: highly cyclical (fair value moves 30%+ on a $200/mt CPO price move); ~1-year Pinago integration risk; Indonesian regulatory volatility (DMO, export centralisation) can decouple realised from headline CPO prices.

Overall score justification

Score reflects the mandate: this is a good-quality, well-managed, fairly-valued plantation stock with zero AI exposure, moderate operating leverage (but the wrong kind — cyclical, not fixed-cost software), high commodity cyclicality, and only single-digit upside to fair value. Downside protection is strong (net cash, hard assets). It would fit a "quality income / cyclical value" mandate; it does not fit an AI-receiver + operating-leverage mandate.